HK innovative drug stocks rise, WuXi Biologics up over 5%, WuXi AppTec up over 4%

HK innovative drug stocks rise, WuXi Biologics up over 5%, WuXi AppTec up over 4%

In a recent development, Hong Kong's innovative drug stocks have experienced a notable uptick, with WuXi Biologics and WuXi AppTec leading the charge. As of July 2, 2025, WuXi Biologics has seen an increase of over 5%, while WuXi AppTec has gained more than 4% [1].

WuXi AppTec, a global leader in R&D and manufacturing services for the pharmaceutical and life sciences industries, has been particularly active in share repurchases. The company recently completed its second RMB1.0 billion A-share repurchase program in 2025, with all repurchased shares set to be cancelled [1]. This program, approved by the company's Annual General Meeting on April 29, 2025, was executed between June 26, 2025, and August 26, 2025. The repurchase included 11,860,809 A-shares, representing 0.40% of the company's total share capital as of August 27, 2025 [1].

So far in 2025, WuXi AppTec has completed a cumulative RMB2.0 billion in A-share repurchases, with all repurchased shares to be cancelled. This year's share repurchases and cash dividends total RMB5.84 billion, representing over 60% of the net profit attributable to the company's owners in 2024 [1]. The company's equity buyback plan, announced on March 17, 2025, has seen the repurchase of 11,860,809 shares, representing 0.35% for CNY 1,000 million [2].

These significant gains and strategic initiatives highlight the positive trajectory of WuXi AppTec and its commitment to enhancing shareholder value. As the company continues to advance healthcare innovation, its stock performance reflects investor confidence in its long-term prospects.

References:
[1] https://www.morningstar.com/news/pr-newswire/20250827cn60216/wuxi-apptec-completes-second-rmb10-billion-a-share-repurchase-program-in-2025-all-repurchased-shares-to-be-cancelled
[2] https://www.marketscreener.com/news/tranche-update-on-wuxi-apptec-co-ltd-s-equity-buyback-plan-announced-on-march-17-2025-ce7c50ded18df223